000 | 01679 a2200493 4500 | ||
---|---|---|---|
005 | 20250512125807.0 | ||
264 | 0 | _c19740213 | |
008 | 197402s 0 0 eng d | ||
022 | _a0002-8703 | ||
024 | 7 |
_a10.1016/0002-8703(74)90396-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShaver, J C | |
245 | 0 | 0 |
_aAnaerobiosis induced by isoproterenol and glucagon in the presence of restricted coronary inflow. _h[electronic resource] |
260 |
_bAmerican heart journal _cJan 1974 |
||
300 |
_a97-104 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAnaerobiosis |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlood Flow Velocity |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 | _aCardiac Catheterization |
650 | 0 | 4 |
_aCardiac Output _xdrug effects |
650 | 0 | 4 | _aCoronary Circulation |
650 | 0 | 4 |
_aCoronary Disease _xmetabolism |
650 | 0 | 4 |
_aCoronary Vessels _xdrug effects |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucagon _xadverse effects |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 | _aInfusions, Parenteral |
650 | 0 | 4 |
_aIsoproterenol _xadverse effects |
650 | 0 | 4 |
_aLactates _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
650 | 0 | 4 |
_aPyruvates _xmetabolism |
650 | 0 | 4 | _aStimulation, Chemical |
650 | 0 | 4 | _aTransducers |
650 | 0 | 4 |
_aVentricular Fibrillation _xchemically induced |
700 | 1 | _aLombardo, A A | |
700 | 1 | _aShaver, V C | |
773 | 0 |
_tAmerican heart journal _gvol. 87 _gno. 1 _gp. 97-104 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-8703(74)90396-2 _zAvailable from publisher's website |
999 |
_c4811958 _d4811958 |